Immunogenic Cell Death and Metabolic Reprogramming in Cancer: Mechanisms, Synergies, and Innovative Therapeutic Strategies
Immunogenic cell death (ICD) is a promising cancer therapy where dying tumor cells release damage-associated molecular patterns (DAMPs) to activate immune responses. Recent research highlights the critical role of metabolic reprogramming in tumor cells, including the Warburg effect, oxidative stress...
Saved in:
| Main Authors: | Jie Jiang, Yan Yan, Chunhui Yang, Hong Cai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/4/950 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications
by: Jun Zhu, et al.
Published: (2025-08-01) -
Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance
by: Jun Lin, et al.
Published: (2025-04-01) -
Targeting Metabolic Reprogramming in Bladder Cancer Immunotherapy: A Precision Medicine Approach
by: Fuyang Liu, et al.
Published: (2025-05-01) -
Reprogramming the tumor-immune landscape via nanomaterial-induced immunogenic cell death: a mini review
by: Xiangwei Meng, et al.
Published: (2025-07-01) -
A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming
by: Mina Afrashteh Nour, et al.
Published: (2025-04-01)